Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00712803 · ClinicalTrials.gov registry record · Phase 1

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy Adults

A Phase 1 study of Dengue, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
Phase 1
Development phase
29
Enrollment target
2
Study locations

NCT00712803 is a Phase 1 study of Dengue that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 29 participants, below the 3,978-participant average among 9 other Dengue trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00712803, a Phase 1 study of Dengue, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
Phase 1
Development phase
29 participants
Enrollment target
2
Study locations

Study Summary

Dengue fever, which is caused by dengue viruses, is a major health problem in tropical and subtropical regions of the world. The purpose of this study is to evaluate the safety of and immune response to a new dengue virus vaccine in healthy adults.

Conditions Studied

Dengue

Interventions

  • BIOLOGICAL rDEN3-3'D4delta30

Study Locations (2)

District of Columbia

  • Center for Immunization Research, Johns Hopkins School of Public Health - Washington D.C.

Maryland

  • Center for Immunization Research, Johns Hopkins University of Public Health - Baltimore

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2008-12
Est. Completion 2009-09
Phase Phase 1

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00712803

The ClinicalTrials.gov registry entry for NCT00712803 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,978-participant average among 9 other Dengue trials with a reported enrollment target (99% lower). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dengue appearing as the primary indexed condition, and to 1 intervention - of which rDEN3-3'D4delta30 is the first listed.

NCT00712803 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Maryland.

Frequently Asked Questions

What is clinical trial NCT00712803 about?

NCT00712803 is a clinical study titled "Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy Adults". Dengue fever, which is caused by dengue viruses, is a major health problem in tropical and subtropical regions of the world. The purpose of this study is to evaluate the safety of and immune response to a new dengue virus vaccine in healthy adults.

What is the current status of trial NCT00712803?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2008-12. Estimated completion is 2009-09.

What conditions does trial NCT00712803 study?

This clinical trial studies the following conditions: Dengue.

What interventions are being tested in trial NCT00712803?

The interventions under investigation include: rDEN3-3'D4delta30 (BIOLOGICAL).

Who is sponsoring clinical trial NCT00712803?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00712803 being conducted?

This trial has 2 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dengue

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dengue

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.